During the past decade, Dallas Oncology Consultants conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dallas Oncology Consultants" are "Cachexia" (1 trials), "Multiple Myeloma" (1 trials), "Ovarian Neoplasms" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Dallas Oncology Consultants" in a lesser frequency.

Most popular intervention types in "Dallas Oncology Consultants" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (1 trials), "Chemotherapy (docetaxel and prednisone)" (1 trials), "Dexamethasone" (1 trials), "GTx-024" (1 trials) and "Immunotherapy allogeneic GM-CSF secreting cellular vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dallas Oncology Consultants" are 2 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dallas Oncology Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dallas Oncology Consultants, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dallas Oncology Consultants, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".